Frozen human skin shown to be more cost-effective than comparable applications

Wound-related costs and number of cell tissue product applications were significantly lower for cryopreserved human skin when compared with bilayered living cell construct and dermal skin substitutes, researchers concluded in a study published in the May issue of Advances in Skin & Wound Care.

The study authors analyzed commercial insurance claims data from 2010 to 2018. They concluded that a statistically significant reduction occurred in the cost of treating diabetic foot ulcers and venous leg ulcers with cryopreserved skin. 

Swift touts outcomes  

With Swift Medical’s artificial intelligence-powered wound care platform deployed across almost 4,000 healthcare facilities in North America, the technology has been shown to speed up wound healing by 37% and reduce wound prevalence by 35%, according to statistics published by the company in June.

The platform also was linked to a 62% reduction in hospital length of stay. Long-term care length of stay was not addressed.

“These outcomes demonstrate the impact of having the most powerful wound image dataset in the world and its ability to deliver high quality wound care with reduced costs,” CEO Brian Litten said.

The Swift Skin & Wound mobile application enables any mobile device to be equipped with AI-powered imaging capabilities to capture high-precision 3-D images, measurements and other clinical data. The imaging enables real-time patient monitoring and decision-making.

Medline optimizes Remedy Skin Care line

Medline recently announced a repackaging initiative for its Remedy Skin Care line as part of what the company says is its commitment to making skin care more intuitive for clinicians. The firm unveiled the changes for attendees at this year’s WOCNext conference in June.

In addition to a unique color coding system meant to enhance efficiency, other advances include packaging and labeling designed to be more useful, as well as education for nurses.

Enhanced color coding on both ends of the product packaging also aligns with the new Coalition for At-Risk Skin’s 21 consensus statements.